Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Switching to next-generation medications Rather than cycling between existing options, the rapidly evolving GLP-1 landscape offers genuinely new medications that may better serve people who have plateaued on semaglutide or tirzepatide
One of its advantages over other antidiabetic drugs is that it has a long duration of action, thus, only once-a-week injection is sufficient
You may qualify if you have: BMI of 30 or greater (obesity) BMI of 27 or greater with at least one weight-related health condition (e.g., high blood pressure, prediabetes, high cholesterol, sleep apnea) 18 years of age or older Difficulty losing weight through diet and exercise alone No contraindications to GLP-1 medications Semaglutide may not be appropriate if you have: Personal or family history of medullary thyroid cancer or MEN2 Active pancreatitis or severe GI disorders Pregnancy or breastfeeding Severe kidney or liver disease Known allergy to semaglutide or GLP-1 medications Uncontrolled eating disorders or severe psychiatric conditions Prescription approval is not guaranteed and is based on medical necessity and provider discretion
Multiple studies have confirmed that six drugs, including liraglutide and semaglutide, have all demonstrated significant dose-dependent weight loss effects [59]
For more on the science behind this approach, visit All About Liposomes
